Pharma Partnering Position HTG's transcriptome-wide profiling and EdgeSeq platform as a rapid route to biomarker discovery and translational research for pharma and biotech collaborators, supported by a track record of partnerships and a clear focus on precision medicine.

Preclinical CRO Services Target CROs and biotech startups with turnkey mouse and whole-transcriptome panels to support preclinical functional research and translational medicine programs, creating a scalable services revenue stream.

Diagnostics Collaboration Explore co-development of diagnostics and companion biomarker tools aligned with HTG's clinical diagnostics ambitions, leveraging its proprietary platform to shorten development timelines.

AI & Data Integration Leverage HTG's collaboration with AI-based cancer decision support to offer data integration and analytics partnerships, enabling customers to fuse transcriptome data with AI tools for decision support.

Growth Levers With a lean team and a history of growth funding, pursue licensing, hosted data analysis, and strategic partnerships to expand market reach across biopharma, CROs, and diagnostics customers.